These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 827229)

  • 1. [Clinical investigation into the action of surheme in perception deafness].
    Berezin A
    Ann Otolaryngol Chir Cervicofac; 1976; 93(7-8):529-32. PubMed ID: 827229
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical trial of butalamine].
    Traissac L
    Rev Laryngol Otol Rhinol (Bord); 1973; 94(9):465-72. PubMed ID: 4603409
    [No Abstract]   [Full Text] [Related]  

  • 3. [Indications of Surheme in otorhinolaryngology. Clinical, audiometric and electronystagmographic study].
    Bertoni R
    Therapeutique; 1971 Nov; 47(9):789-96. PubMed ID: 5147558
    [No Abstract]   [Full Text] [Related]  

  • 4. [Surheme in the treatment of cochleo-vestibular syndromes of vascular origin].
    Meunier JL; Forestier R
    Ann Otolaryngol Chir Cervicofac; 1973 Jun; 90(6):397-407. PubMed ID: 4541765
    [No Abstract]   [Full Text] [Related]  

  • 5. [Diagnosis and treatment of cochleo-vestibular disorders (clinical study of Surheme)].
    el Seifi A
    Rev Laryngol Otol Rhinol (Bord); 1976; 97(3-4):181-8. PubMed ID: 827003
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical and thermometric study of Surheme in 30 cases of cerebrovascular disorders].
    Balmes A; Piglowski J
    Therapeutique; 1973; 49(5):361-7. PubMed ID: 4781830
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of sound perception deafness with Danaden retard].
    Koeppel FW
    MMW Munch Med Wochenschr; 1976 Aug; 118(32-33):1015-6. PubMed ID: 822295
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of surheme on improved blood flow in limbs].
    Wesolowski J; Hubl S; Godziemba-Maliszewska E
    Wiad Lek; 1972 Jul; 25(14):1297-300. PubMed ID: 5054661
    [No Abstract]   [Full Text] [Related]  

  • 9. [Betaserc (Betahistine-HC1) in the treatment of acute deafness].
    Grahne B; Paavolainen M
    Med Monatsschr; 1976 Jun; 30(6):273-5. PubMed ID: 787749
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pyrithioxine (Encephabol); report of a double blind study of the action of pyrithioxine (Encephabol) in patients suffering from central deafness].
    Nelemans FA
    Ned Tijdschr Geneeskd; 1966 Nov; 110(45):2002-5. PubMed ID: 5342108
    [No Abstract]   [Full Text] [Related]  

  • 11. [Surheme in chronic obliterative arteriopathies of the lower limbs].
    Desruelles J; Waucampt JJ
    Lille Med; 1971 Jan; 16():Suppl 1:224-9. PubMed ID: 5162043
    [No Abstract]   [Full Text] [Related]  

  • 12. Electrostimulation for sensorineural hearing impairment: change of W-22 scoring ability during a new procedure.
    Hughes EC; Arthur RH; Whitaker CW
    Eye Ear Nose Throat Mon; 1974 Feb; 53(2):62-8. PubMed ID: 4592128
    [No Abstract]   [Full Text] [Related]  

  • 13. [Is all chronic neurosensory deafness irreversible?].
    Sala O; Babighian G
    Rev Laryngol Otol Rhinol (Bord); 1972; 93(9):513-22. PubMed ID: 4348366
    [No Abstract]   [Full Text] [Related]  

  • 14. [Perception deafness caused by direct or indirect injuries. (Occupational deafness excluded). Treatment--long-term prognosis].
    Pantazopoulos P; Alcalakis V; Dokianakis G; Nomicos N; Papafragos C
    Minerva Otorinolaringol; 1970; 20(5):188-91. PubMed ID: 5514239
    [No Abstract]   [Full Text] [Related]  

  • 15. [Surheme (Butalamine) in the treatment of vertigo].
    Zmigrodzka K
    Otolaryngol Pol; 1976; 30(3):227-33. PubMed ID: 823509
    [No Abstract]   [Full Text] [Related]  

  • 16. Proxazole in cerebrovascular insufficiency. A controlled clinical trial.
    Esposito G; De Gregorio M
    Arzneimittelforschung; 1974 Oct; 24(10):1692-6. PubMed ID: 4611436
    [No Abstract]   [Full Text] [Related]  

  • 17. [Surheme in rheumatology].
    Chabot J
    Therapeutique; 1971; 47(6):615-8. PubMed ID: 5571180
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of sensory-neural deafness and tinnitus with a nucleic acid derivative.
    Makishima K; Yasuda K; Myahara T; Komiyama S; Kato T; Kawata S
    Arzneimittelforschung; 1971 Sep; 21(9):1343-9. PubMed ID: 4944968
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of molsidomine in patients with coronary disease].
    Goch JH; Rosiek S; Brzozowski R; Bała T; Tkaczewski W; Adamska-Dyniewska H
    Pol Tyg Lek; 1985 Jul; 40(29):829-31. PubMed ID: 3903695
    [No Abstract]   [Full Text] [Related]  

  • 20. [Various reflections apropos of the use of PC 63-14 in reception deafness].
    Portmann M; Lacher G
    Rev Laryngol Otol Rhinol (Bord); 1968; 89(7):502-4. PubMed ID: 4388110
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.